Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Enabling CAR T-cell therapies for HIV-positive lymphoma patients - A call for action.
HIV Med. 2023 Sep;24(9):957-964. doi: 10.1111/hiv.13514. Epub 2023 Jun 15.
HIV Med. 2023.
PMID: 37322863
Review.
Characteristics and outcomes of sepsis patients with and without COVID-19.
Heubner L, Hattenhauer S, Güldner A, Petrick PL, Rößler M, Schmitt J, Schneider R, Held HC, Mehrholz J, Bodechtel U, Ragaller M, Koch T, Spieth PM.
Heubner L, et al. Among authors: hattenhauer s.
J Infect Public Health. 2022 Jun;15(6):670-676. doi: 10.1016/j.jiph.2022.05.008. Epub 2022 May 16.
J Infect Public Health. 2022.
PMID: 35617831
Free PMC article.
Item in Clipboard
Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors.
Mispelbaum R, Hattenhauer ST, Brossart P, Heine A.
Mispelbaum R, et al. Among authors: hattenhauer st.
Front Immunol. 2022 Sep 8;13:976011. doi: 10.3389/fimmu.2022.976011. eCollection 2022.
Front Immunol. 2022.
PMID: 36159812
Free PMC article.
Item in Clipboard
Baseline immune signature score of Tregs × HLA-DR+CD4+ T cells × PD1+CD8+ T cells predicts outcome to immunotherapy in cancer patients.
Mispelbaum R, Hattenhauer ST, Held SAE, Brossart P, Heine A.
Mispelbaum R, et al. Among authors: hattenhauer st.
Front Immunol. 2022 Nov 28;13:1054161. doi: 10.3389/fimmu.2022.1054161. eCollection 2022.
Front Immunol. 2022.
PMID: 36518753
Free PMC article.
Item in Clipboard
Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial.
Kiss T, Wittenstein J, Becker C, Birr K, Cinnella G, Cohen E, El Tahan MR, Falcão LF, Gregoretti C, Granell M, Hachenberg T, Hollmann MW, Jankovic R, Karzai W, Krassler J, Loop T, Licker MJ, Marczin N, Mills GH, Murrell MT, Neskovic V, Nisnevitch-Savarese Z, Pelosi P, Rossaint R, Schultz MJ, Serpa Neto A, Severgnini P, Szegedi L, Vegh T, Voyagis G, Zhong J, Gama de Abreu M, Senturk M; PROTHOR investigators; Research Workgroup PROtective VEntilation Network (PROVEnet) of the European Society of Anaesthesiology (ESA).
Kiss T, et al.
Trials. 2019 Apr 11;20(1):213. doi: 10.1186/s13063-019-3208-8.
Trials. 2019.
PMID: 30975217
Free PMC article.
Item in Clipboard
Cite
Cite